for Journals by Title or ISSN
for Articles by Keywords
Followed Journals
Journal you Follow: 0
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover Medtech Insight
  [0 followers]  Follow
   Full-text available via subscription Subscription journal
   ISSN (Print) 1876-8008
   Published by Informa plc Homepage  [16 journals]
  • Robotic-Assisted Surgery: Taking MIS By Storm
    • Abstract: Robotically assisted surgical devices are one of the hottest and fastest growing segments in the market for minimally invasive surgery (MIS) products, with a global market opportunity projected to reach more than $10 billion by 2021. A growing number of competitors hope to capture share and further expand the market by targeting key procedures and geographies with next generation robotic surgery systems and robotic-like technologies designed to improve outcomes and enable more complex procedures to be performed via an MIS approach.
      PubDate: Thu, 26 May 2016 03:00:06 -040
  • MiNDERA Corp.
    • Abstract: MiNDERA Corp. is developing an alternative to punch biopsies for diagnosing skin cancer: its microneedle device extracts biomarkers from the skin in a procedure that the start-up says is highly accurate and cost-effective for office-based diagnostic applications in dermatology.
      PubDate: Thu, 26 May 2016 03:00:01 -040
  • Sinclair Pharma's Non-Surgical Facelift Gains Access To US Market Via
           Thermigen Deal
    • Abstract: Sinclair Pharma has gained access to the world’s largest aesthetics market by enlisting Thermigen as the exclusive US distributor of Silhouette InstaLift, a non-surgical alternative to facelifts.
      PubDate: Tue, 24 May 2016 03:00:18 -040
  • 4Tech Inc.
    • Abstract: 4Tech Inc. has developed a dedicated transcatheter system to treat tricuspid regurgitation. ItsTriCinch applies tension to an anchor placed on the annulus of the tricuspid valve, thus reducing the size of the native annulus and limiting the amount of blood that can backflow through the valve.
      PubDate: Tue, 24 May 2016 03:00:02 -040
  • Siemens Makes First Molecular Dx Buy In 9 Years
    • Abstract: Siemens Healthineers, the new brand name for Siemens Healthcare, has acquired NEO New Oncology, a privately held German company developing molecular profiling assays based on next-generation sequencing of circulating tumor DNA. The deal marks Siemens’ first molecular diagnostic acquisition since it bought US firm Dade Behring for $7bn in 2007.
      PubDate: Thu, 19 May 2016 03:00:06 -040
  • Medtronic Bets On Future Mazor Robotics Spine Surgery Systems
    • Abstract: Medtronic is putting its sales and marketing power behind Israel-based Mazor Robotics with new commercial agreement and investment deals, both announced May 18.
      PubDate: Thu, 19 May 2016 03:00:02 -040
  • TEVAR 2016: Companies Push New Frontiers In Thoracic Aortic Interventions
    • Abstract: Although thoracic endovascular aortic repair (TEVAR) is now routine for lesions like dissection of the descending aorta, the Big Three aortic endovascular companies are developing devices for the more technically challenging proximal and distal portions of the thoracic aorta while physicians refine TEVAR in the descending aorta. Insiders say endovascular techniques are overcoming limitations and physicians will soon be able to treat the entire aorta, from the aortic valve to the bifurcation.
      PubDate: Tue, 17 May 2016 03:00:00 -040
  • EFFORTLESS Trial Of Boston Scientific’s S-ICD Headlines HRS 2016
    • Abstract: Results from EFFORTLESS, the largest post-market registry of Boston Scientific’s S-ICD (subcutaneous ICD), support the technology as an option for a broad population of ICD candidates. Researchers presented data from the registry on May 6 at the Heart Rhythm Society Scientific Sessions in San Francisco.
      PubDate: Thu, 12 May 2016 03:00:04 -040
  • HRS 2016 ROUND-UP: Medtronic Unveils New “Extravascular ICD”
    • Abstract: The 2016 Heart Rhythm Society’s Annual Scientific Sessions were held in San Francisco on May 4-7 and featured over 250 educational sessions on cardiac rhythm management and electrophysiology, including presentations of new clinical data from medical device trials. Here are some of the highlights.
      PubDate: Thu, 12 May 2016 03:00:00 -040
  • FDA Turns Down Sensor-Embedded Tablet For Monitoring Medication Adherence
    • Abstract: The agency says it needs more information, and especially more usability testing, before it can approve a new drug application on a combination product that integrates Otsuka’s Abilify antipsychotic with an ingestible sensor made by Proteus, intended to improve medication adherence.
      PubDate: Tue, 10 May 2016 03:00:00 -040
  • Medtech Execs On The Move, May 2016
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Thu, 05 May 2016 03:00:08 -040
  • Medical Device Deals Update, May 2016
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced March-April 2016.
      PubDate: Thu, 05 May 2016 03:00:02 -040
  • Global Radiation Therapy Systems Market Expected to Reach $5.6B by 2020
    • Abstract: Although immunotherapy and other cutting-edge technologies have dominated the spotlight in cancer treatment over the last several years, the use of radiation therapy is rapidly increasing as physicians look to this non-invasive, cost-effective treatment to address a broad and growing number of cancers. Valued at nearly $4.3 billion in 2015, the global radiation therapy market is growing at a CAGR of 5.5%, and is projected to reach $5.6 billion by 2020, according to a recent report from Medtech Insight.
      PubDate: Tue, 03 May 2016 03:00:02 -040
  • Stealth Robot-Maker Auris Buys Hansen for $80 Million
    • Abstract: Auris, which is backed by serial surgical robotic entrepreneur Frederic Moll, picked up the struggling Hansen, which makes robotic catheter systems for electrophysiology and vascular interventions.
      PubDate: Thu, 28 Apr 2016 03:00:10 -040
  • First Endovascular Neural Interface Eyed By New Firm Synchron
    • Abstract: The company launched in Silicon Valley on April 21 with plans to develop a device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.
      PubDate: Thu, 28 Apr 2016 03:00:00 -040
  • NuCryo Vascular: The Return Of PolarCath For
           Peripheral Vascular Disease
    • Abstract: Despite enthusiastic uptake by cardiologists when it was first introduced, cryoplasty has become the poor relation of the interventional peripheral vascular disease treatment sector. A new version of a pioneering product is back on the market, thanks to start-up NuCryo Vascular.
      PubDate: Tue, 26 Apr 2016 03:00:09 -040
  • Total Joints: Bundled Payments Driving Procedural Innovation
    • Abstract: Manufacturers bracing for CMS' new mandatory bundled payment program for total hip and knee replacement surgery may be able to breathe a sigh of relief as hospitals are expected to target post-acute-care rather than implants to bring down costs. Amid these changes, orthopedic manufacturers are helping hospitals address bundled payments by developing innovative solutions that improve procedural efficiencies, recovery times, costs and patient outcomes, including outpatient total joint surgery, robotics, custom implants, and patient-specific instrumentation.
      PubDate: Tue, 26 Apr 2016 03:00:01 -040
  • AACR-ROUND-UP: A Novel Drug Delivery System And More Liquid Biopsy Results
           Highlight New Orleans Meeting
    • Abstract: Highlights from the American Association for Cancer Research (AACR) Annual Meeting on April 19 include an implantable microdevice for evaluating drug efficacy in treating breast cancer tumors, as well as the latest research and innovation in liquid biopsy testing.
      PubDate: Thu, 21 Apr 2016 03:00:16 -040
  • MediBeacon Inc.
    • Abstract: The Optical Renal Function Monitor from MediBeacon Inc. could overcome the shortcomings of blood tests to measure renal function by using an external light sensor placed on the skin, and then administering a proprietary biocompatible tracer. The technology can measure kidney function in real time at the point of care.
      PubDate: Thu, 21 Apr 2016 03:00:02 -040
  • Chronix's Liquid Biopsy Test Shows Promise In Predicting Therapeutic
           Response To Chemo
    • Abstract: Chronix Biomedical's blood-based liquid biopsy test showed promise in predicting therapeutic response to chemotherapy in a blinded proof-of-concept study presented at the American Association for Cancer Research (AACR) annual meeting in New Orleans, Louisiana (April 16-20).
      PubDate: Tue, 19 Apr 2016 03:00:00 -040
  • Epigenomics Finally Gains FDA Approval For Epi proColon Blood Test
    • Abstract: Epigenomics has finally gained US FDA approval for its Epi proColon noninvasive colorectal cancer screening test, ending what has been a long, obstacle-filled journey for the German-US molecular diagnostics company.
      PubDate: Thu, 14 Apr 2016 03:00:13 -040
  • Doctor-Created Device Turns To Crowdfunding
    • Abstract: The Omni-Pro “14-in-one” integrates a range of common exam-room tools into a stethoscope-mounted unit. It has raised $6,000 on crowdfunding site Indiegogo since March 20.
      PubDate: Thu, 14 Apr 2016 03:00:06 -040
  • Teleflex Bets Percutaneous Laparoscopy Will Be MIS Game Changer
    • Abstract: Story and Podcast: Teleflex Medical launched in March a novel portfolio of miniaturized percutaneous surgical instruments that have the same functionality as full-sized laparoscopic instruments, but allow surgeons to access the abdominal cavity using trocar-less entry and much smaller incisions than those required in traditional laparoscopy. Teleflex execs say the technology is a game changer, and the company hopes percutaneous laparoscopy will become the standard of care for the 4 million laparoscopic procedures performed annually in the US.
      PubDate: Thu, 14 Apr 2016 03:00:02 -040
  • Medtech Execs On The Move, April 2016
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Tue, 12 Apr 2016 03:00:00 -040
  • EVAR Update: Companies Target Complex Anatomies With Innovative Solutions
    • Abstract: As endovascular aortic repair (EVAR) becomes a mainstream procedure, companies are racing to develop products that can treat patients with more challenging anatomy. As the space bubbles with ongoing trials and new-product launches, newer companies hope to make their mark in a space dominated by the established market leaders Medtronic PLC, Cook Medical Inc. and WL Gore & Associates.
      PubDate: Thu, 07 Apr 2016 03:00:02 -040
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015